Business
Australia to consider EU and UK findings over AstraZeneca Covid vaccine and blood clots – The Guardian
Review follows a UK decision to offer people under 30 an alternative jab following formal link to rare blood clots
Vaccines and immunisation
Australian authorities will review the findings of British and European regulators over concerns about the AstraZeneca Covid-19 vaccine but continue to emphasise that the benefits outweigh the risks.
The review follows a decision in the United Kingdom to offer healthy adults aged under 30 an alternative to the Oxford/AstraZeneca jab following concerns over rare blood clots.
The European Medicines Agency also announced on Wednesday that the rare blood clots would be listed…
-
Noosa News23 hours agoSwastika, anti-Islam graffiti sprayed on Brisbane mosque
-
General17 hours agoOne more time around • Inside Story
-
Noosa News20 hours agoThe Best Hotels Across The World, According To Our Editors
-
General20 hours agoDimboola woman who told undercover police she gouged elderly man’s eyes found not guilty of murder